Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance

被引:128
作者
Chauhan, D
Li, GL
Hideshima, T
Podar, K
Mitsiades, C
Mitsiades, N
Catley, L
Tai, YT
Hayashi, T
Shringarpure, R
Burger, R
Munshi, N
Ohtake, Y
Saxena, S
Anderson, KC
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[2] Asahi Breweries Ltd, Tokyo, Japan
[3] Lovelace Resp Res Inst, Albuquerque, NM USA
关键词
D O I
10.1182/blood-2003-05-1417
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Smac, second mitochondria-derived activator of caspases, promotes apoptosis via activation of caspases. Heat shock protein 27 (Hsp27) negatively regulates another mitochondrial protein, cytochrome c, during apoptosis; however, the role of Hsp27 in modulating Smac release is unknown. Here we show that Hsp27 is overexpressed in both dexamethasone (Dex)-resistant multiple myeloma (MM) cell lines (MM.1R, U266, RPMI-8226) and primary patient cells. Blocking Hsp27 by an antisense (AS) strategy restores the apoptotic response to Dex in Dex-resistant MM cells by triggering the release of mitochondrial protein Smac, followed by activation of caspase-9 and caspase-3. Moreover, AS-Hsp27 overcomes interleukin-6 (IL-6)-mediated protection against Dex-induced apoptosis. These data demonstrate that Hsp27 inhibits the release of Smac, and thereby confers Dex resistance in MM cells. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3379 / 3386
页数:8
相关论文
共 58 条
  • [1] ALEXANIAN R, 1983, BLOOD, V62, P572
  • [2] Moving disease biology from the lab to the clinic
    Anderson, KC
    [J]. CANCER, 2003, 97 (03) : 796 - 801
  • [3] Apoptosis: checkpoint at the mitochondrial frontier
    Bossy-Wetzel, E
    Green, DR
    [J]. MUTATION RESEARCH-DNA REPAIR, 1999, 434 (03): : 243 - 251
  • [4] RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells
    Chauhan, D
    Hideshima, T
    Pandey, P
    Treon, S
    Teoh, G
    Raje, N
    Rosen, S
    Krett, N
    Husson, H
    Avraham, S
    Kharbanda, S
    Anderson, KC
    [J]. ONCOGENE, 1999, 18 (48) : 6733 - 6740
  • [5] Apoptotic signaling in multiple myeloma: Therapeutic implications
    Chauhan, D
    Hideshima, T
    Anderson, KC
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (02) : 114 - 120
  • [6] Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells
    Chauhan, D
    Pandey, P
    Ogata, A
    Teoh, G
    Krett, N
    Halgren, R
    Rosen, S
    Kufe, D
    Kharbanda, S
    Anderson, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) : 29995 - 29997
  • [7] Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications
    Chauhan, D
    Anderson, KC
    [J]. APOPTOSIS, 2003, 8 (04) : 337 - 343
  • [8] Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
    Chauhan, D
    Li, GL
    Auclair, D
    Hideshima, T
    Richardson, P
    Podar, K
    Mitsiades, N
    Mitsiades, C
    Li, C
    Kim, RS
    Munshi, N
    Chen, LB
    Wong, W
    Anderson, KHC
    [J]. BLOOD, 2003, 101 (09) : 3606 - 3614
  • [9] Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays
    Chauhan, D
    Auclair, D
    Robinson, EK
    Hideshima, T
    Li, GL
    Podar, K
    Gupta, D
    Richardson, P
    Schlossman, RL
    Krett, N
    Chen, LB
    Munshi, NC
    Anderson, KC
    [J]. ONCOGENE, 2002, 21 (09) : 1346 - 1358
  • [10] 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells
    Chauhan, D
    Catley, L
    Hideshima, T
    Li, GL
    Leblanc, R
    Gupta, D
    Sattler, M
    Richardson, P
    Schlossman, RL
    Podar, K
    Weller, E
    Munshi, N
    Anderson, KC
    [J]. BLOOD, 2002, 100 (06) : 2187 - 2194